p53 regulates the effects of DAPT on Rac1 activation and migration of non-small-cell lung cancer cells

The use of ??-secretase inhibitors to inhibit the activation of Notch receptors can effectively inhibit the malignant process of tumors. Here, we demonstrate that p53 can modulate the effect of DAPT (a ??-secretase inhibitor) on the activation of small GTPase Rac1, thereby affecting cell migration of non-small-cell lung cancer H1299 and A549 cells. After treatment with 20 ??M DAPT, activation of Rac1 was increased in H1299 cells but not in A549 cells. We further found that the migration ability of H1299 cells was increased, whereas that of A549 cells was reduced. The effect of DAPT on H1299 migration was repressed by Rac1-T17N, a dominant inactivated mutant of Rac1. H1299 is a p53-deficient cell line. When p53 protein was overexpressed in H1299 cells with a pEGFP-p53 plasmid, DAPT treatment no longer activated Rac1 and increased migration ability. Moreover, DAPT promoted the migration of H1299 cells by increasing the activity of Rac1 through the non -canonical Notch pathway. Taken together, these results indicate that the expression of p53 pro-tein in lung cancer cells regulates the effect of DAPT on cell migration by modulating the acti-vation of Rac1, suggesting that p53 may affect the therapeutic effects of Notch inhibitors in lung cancer patients.